Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MABT403 Anti-Proteinase 3/PR3 Antibody, clone MCPR3-7

MABT403
100 μg  
Purchase on Sigma-Aldrich

Speciální nabídky

Přehled

Replacement Information

Speciální nabídky

Tabulka spec. kláve

Species ReactivityKey ApplicationsHostFormatAntibody Type
HWB, ABA, FC, IP, INHIBMPurifiedMonoclonal Antibody
Description
Catalogue NumberMABT403
DescriptionAnti-Proteinase 3/PR3 Antibody, clone MCPR3-7
Alternate Names
  • Myeloblastin
  • AGP7
  • C-ANCA antigen
  • Leukocyte proteinase 3
  • Neutrophil proteinase 4
  • NP-4
  • P29
  • PR-3
  • PR3
  • Wegener autoantigen
Background InformationMyeloblastin (EC 3.4.21.76; UniProt P24158; also known as AGP7, C-ANCA antigen, Leukocyte proteinase 3, Neutrophil proteinase 4, NP-4, P29, PR-3, PR3, Wegener autoantigen) is encoded by the PRTN3 (also known as CANCA, MBN, NP4) gene (Gene ID 5657) in human. Proteinase 3 (PR3) is one of four neutral serine proteases (elastase, cathepsin G, PR3, and neutrophil serine protease 4) stored as fully processed mature enzymes in azurophil granules of human neutrophils. Instead of being targeted to granules after their synthesis, some PR3 molecules end up on the surface of neutrophil plasma membrane in either pro- or mature form. The degree of such surface expression is genetically determined, but the surface exposure and pericellular activity of PR3 around neutrophils can be further upregulated upon neutrophil priming and activation. PR3 autoantibody (anti-neutrophil cytoplasmic antibodies or ANCA) is the main pathogenic feature in patients suffering from granulomatosis with polyangiitis (GPA; formerly called Wegener granulomatosis). ANCAs are shown to activate cytokine-primed neutrophils in vitro by cross-linking surface-exposed PR3 and Fcγ receptors. PR3 activity and/or its inactivation by alpha 1-antitrypsin/alpha-1 proteinase inhibitor (α1PI) varies in the human population and contributes to the risk for GPA manifestations either at onset, during relapses, or during systemic progression. PR3 is initially produced with a signal peptide sequence (a.a. 1-25), an N-terminal and a C-terminal propeptide sequence (a.a. 26-27 and 249-256, respectively), the removal of which yields the mature enzyme (a.a. 28-248).
References
Product Information
FormatPurified
PresentationPurified mouse monoclonal IgG1κ antibody in PBS without preservatives.
Quality LevelMQ100
Applications
ApplicationAnti-Proteinase 3/PR3 Antibody, clone MCPR3-7 is an antibody against PR3 for use in Affinity Binding Assay, Flow Cytometry, Immunoprecipitation, Inhibition Assay, and Western Blotting.
Key Applications
  • Western Blotting
  • Affinity Binding Assay
  • Flow Cytometry
  • Immunoprecipitation
  • Inhibits Activity/Function
Application NotesWestern Blotting Analysis: 1-2 µg/mL from a representative lot detected 1 µg of recombinant human pro-PR3 under non-reducing condition, but not under reducing condition (Courtesy of Amber Hummel, Mayo Clinic, Rochester, MN).
Flow Cytometry Analysis: A representative lot immunostained the surface of only a small subpopulation of human peripheral blood neutrophils that are stained positive with clone MCPR3-2 (Cat. No. MABT340), consistent with the surface PR3 being in an active conformation complexed with CD177 and/or lipid bilayers. (Hinkofer, L.C., et al. (2013). J. Biol. Chem. 288(37):26635-26648).
Flow Cytometry Analysis: A representative lot bound recombinant human PR3-, but not murine PR3-, coated Talon-beads as determined by FACS analysis. (Silva, F., et al. (2010). J. Autoimmun. 35(4) 299-308).
Flow Cytometry Analysis: A representative lot bound immobilized recombinant human PR3 via a distinct epitope than those recognized by clone MCPR3-2 and MCPR3-3 (Cat. No. MABT340 and MABF973, respectively) as determined by FACS analysis of bead-based competition binding assay (Silva, F., et al. (2010). J. Autoimmun. 35(4) 299-308).
Immunoprecipitation Analysis: A representative lot immunoprecipitated a recombinant human PR3 construct proP-PR3ctp that adopts a pro-PR3 conformation, while exhibiting greater than 75% reduced affinity toward a recombinant construct ΔPR3ctp-S195A that adopts a mature PR3 conformation (Hinkofer, L.C., et al. (2013). J. Biol. Chem. 288(37):26635-26648).
Inhibition Analysis: A representative lot caused a substrate-dependent inhibition against human PR3 enzymatic activity by altering PR3 S1' pocket conformation, but not PR3 S1 pocket conformation (Hinkofer, L.C., et al. (2013). J. Biol. Chem. 288(37):26635-26648).
Affinity Binding Assay: A representative lot captured a recombinant human PR3 construct proP-PR3ctp that adopts a pro-PR3 conformation, while exhibiting greater than 75% reduced affinity toward a recombinant construct ΔPR3ctp-S195A that adopts a mature PR3 conformation (Hinkofer, L.C., et al. (2013). J. Biol. Chem. 288(37):26635-26648).
Biological Information
ImmunogenRecombinant proP-PR3ctp (Hinkofer, L.C., et al. (2013). J. Biol. Chem. 288(37):26635-26648).
EpitopeA hydrophobic region of the activation domain (Hinkofer, L.C., et al. (2013). J. Biol. Chem. 288(37):26635-26648; Silva, F., et al. (2010). J. Autoimmun. 35(4) 299-308).
CloneMCPR3-7
ConcentrationPlease refer to lot specific datasheet.
HostMouse
SpecificityClone MCPR3-7 targets a hydrophobic region of the activation domain involved in the binding of human PR3 to neutrophil membrane receptor NB1/CD177. Clone MCPR3-7 preferentially recognizes PR3 in a pro-form conformation and causes a substrate-dependent inhibition against human PR3 enzymatic activity by altering PR3 S1' pocket conformation, but not PR3 S1 pocket conformation (Hinkofer, L.C., et al. (2013). J. Biol. Chem. 288(37):26635-26648).
IsotypeIgG1κ
Species Reactivity
  • Human
Species Reactivity NoteHuman. Not mouse.
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Gene Symbol
  • PRTN3
  • CANCA
  • MBN
  • NP4
Purification MethodProtein G Purified
UniProt Number
Molecular Weight~32 kDa observed. 27.81 kDa (Pro-PR3; a.a. 1-256), 25.14 kDa (N-terminal signal and propeptide removed; a.a. 28-256), 24.25 kDa (Mature; a.a. 28-248) calculated.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceIdentity Confirmation by Isotyping Test.

Isotyping Analysis: The identity of this monoclonal antibody is confirmed by isotyping test to be IgG1κ.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Packaging Information
Material Size100 μg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
MABT403 04055977333619

Documentation

Anti-Proteinase 3/PR3 Antibody, clone MCPR3-7 MSDS

Title

Safety Data Sheet (SDS) 

Anti-Proteinase 3/PR3 Antibody, clone MCPR3-7 Certificates of Analysis

TitleLot Number
Anti-Proteinase 3/PR3, -Q2667551 Q2667551
Anti-Proteinase 3/PR3, clone MCPR3-7 - 3184985 3184985
Anti-Proteinase 3/PR3, clone MCPR3-7 - 3234454 3234454
Anti-Proteinase 3/PR3, clone MCPR3-7 - 3328862 3328862
Anti-Proteinase 3/PR3, clone MCPR3-7 - 3880956 3880956
Anti-Proteinase 3/PR3, clone MCPR3-7 - 4107720 4107720
Anti-Proteinase 3/PR3, clone MCPR3-7 - 4190476 4190476
Anti-Proteinase 3/PR3, clone MCPR3-7 - 4194243 4194243